CAF Mourns Passing of Barry and Honey Sherman
December 19, 2017 – The Cooley’s Anemia Foundation pays tribute to Barry and Honey Sherman, who tragically passed away last week. Barry Sherman was the founder of Apotex, the pharmaceutical company which is responsible for bringing the oral chelator Ferriprox to the market in the United States and in countries around the world. It is largely due to Barry’s dedication and determination that this drug is now available as a treatment option for millions of thalassemia patients. There were many unique challenges involved in making Ferriprox accessible, and these challenges presented circumstances which would have daunted and discouraged a less determined, less compassionate and less visionary man. But Barry knew of the importance of this medication in human terms and felt that this importance demanded that the obstacles be overcome, no matter the cost.
The Foundation was fortunate to have Barry as a speaker at its 2017 Gala; his insightful comments were a highlight of the evening. He was accompanied to the Gala by Honey, whose humor and warmth charmed all who met her; Honey was clearly very much a part of Barry’s success and seeing her with Barry made one appreciate how much she brought to their relationship and to their combined accomplishments. The Foundation feels blessed to have had the opportunity to welcome the Shermans on behalf of the entire thalassemia population, both in the United States and around the world. The lives and futures of those with thalassemia have been immeasurably enriched by their efforts.
The Foundation extends its deepest sympathy to the members of the Sherman family and their friends, as well as to the officers and employees of Apotex.